Fundamentals Overview
ResMed Inc. is near the low of its 52-week range with moderate valuation, trending downward today.
Valuation moderate
Intrinsic value (DCF)
+58.1% upside vs price
Profitability
Risk (Beta)
0.78 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +58.1% upside vs price · Analyst grade: A
Pressures (Sell):
Sentiment weakening (2 downgrades) · 3M vs S&P 500: -25.8% · 3M vs Healthcare sector: -23.2%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: A. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 4, Equal Weight: 4, Hold: 4, Neutral: 3, Outperform: 10, Overweight: 5.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $305.07; current price is $193.01. That’s a +58.1% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 18.68 |
| DCF value (model) | $305.07 (58.1% upside) |
| PEG (TTM) | 1.19 |
| P/B (TTM) | 4.35 |
| P/S (TTM) | 5.06 |
| P/FCF (TTM) | 16.01 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 3.01 |
| Quick Ratio (TTM) | 2.33 |
| Cash Ratio (TTM) | 1.23 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 27.44% |
| Gross margin (TTM) | 61.69% |
| Operating margin (TTM) | 34.28% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for RMD.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Jefferies | maintain | Hold | Hold | 2026-07-10 |
| RBC Capital | maintain | Outperform | Outperform | 2026-07-08 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-07-08 |
| Keybanc | maintain | Overweight | Overweight | 2026-06-22 |
| Morgan Stanley | downgrade | Overweight | Equal Weight | 2026-06-17 |
| Citigroup | maintain | Buy | Buy | 2026-06-15 |
| RBC Capital | maintain | Outperform | Outperform | 2026-05-01 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-05-01 |
| Keybanc | maintain | Overweight | Overweight | 2026-04-27 |
| Citigroup | maintain | Buy | Buy | 2026-04-09 |
| Citigroup | maintain | Buy | Buy | 2026-02-02 |
| Piper Sandler | maintain | Neutral | Neutral | 2026-01-30 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-01-30 |
| Stifel | maintain | Hold | Hold | 2026-01-30 |
| RBC Capital | maintain | Outperform | Outperform | 2026-01-30 |
| Stifel | maintain | Hold | Hold | 2025-12-18 |
| Baird | downgrade | Outperform | Neutral | 2025-12-16 |
| Baird | maintain | Outperform | Outperform | 2025-11-03 |
| RBC Capital | maintain | Outperform | Outperform | 2025-10-31 |
| Mizuho | maintain | Outperform | Outperform | 2025-10-31 |
| Keybanc | maintain | Overweight | Overweight | 2025-10-31 |
| Morgan Stanley | maintain | Overweight | Overweight | 2025-10-21 |
| Keybanc | maintain | Overweight | Overweight | 2025-08-01 |
| Piper Sandler | maintain | Neutral | Neutral | 2025-08-01 |
| Mizuho | maintain | Outperform | Outperform | 2025-08-01 |
| Stifel | maintain | Hold | Hold | 2025-08-01 |
| RBC Capital | maintain | Outperform | Outperform | 2025-08-01 |
| UBS | maintain | Buy | Buy | 2025-08-01 |
| RBC Capital | upgrade | Sector Perform | Outperform | 2025-07-16 |
| Mizuho | maintain | Outperform | Outperform | 2025-07-16 |